Craft

Silo Pharma

Stock Price

$1.1

2024-10-29

Market Capitalization

$5.2 M

2024-10-29

Revenue

$72.1 K

FY, 2025

Silo Pharma Summary

Company Summary

Overview
Silo Pharma is a developmental stage biopharmaceutical company focusing on merging traditional therapeutics with psychedelic research for people suffering from neurological disorders. It offers a variety of drugs targeting such diseases as Alzheimer’s, PTSD, multiple sclerosis, rheumatoid arthritis, stress-induced affective disorders, etc.
Type
Public
Status
Active
Founded
2010
HQ
Englewood Cliffs, NJ, US | view all locations
Website
https://silopharma.com/
Cybersecurity rating
Sectors

Key People

  • Eric Weisblum

    Eric Weisblum, CEO

    • Kevin Muñoz

      Kevin Muñoz, Board Member

      • Wayne Linsley

        Wayne Linsley, Board Member

        • James Kuo

          James Kuo, Vice President of R&D

        LocationsView all

        1 location detected

        • Englewood Cliffs, NJ HQ

          United States

          560 Sylvan Ave #3160

        Silo Pharma Financials

        Summary Financials

        Revenue (Q1, 2026)
        $18.0K
        Gross profit (Q1, 2026)
        ($2.7K)
        Net income (Q1, 2026)
        ($1.6M)
        Cash (Q1, 2026)
        $3.9M
        EBIT (Q1, 2026)
        ($1.6M)

        Footer menu